PG Form 4: COO Jejurikar Disposes 28,036 Shares; Receives 26,231-Share Option
Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported transactions dated 09/15/2025.
Rhea-AI Filing Summary
Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), reported transactions dated 09/15/2025. The filing shows a disposition of 28,036.3817 shares of Common Stock and the acquisition of a stock option award for 26,231 underlying shares with an exercise price of $156.83. The option award is listed as acquired on 09/15/2025, becomes exercisable on 09/15/2028 and expires 09/14/2035. The report lists indirect beneficial ownership stakes of 3,301.9815 shares held by a retirement plan trustee, 19,757 shares held by the Sankhya S Jejurikar Revocable Trust, and 17,849 shares held by the Shailesh Jejurikar Trust. The form is signed by an attorney-in-fact on 09/17/2025.
Positive
- Option award disclosed with clear exercise price ($156.83), exercisability date (09/15/2028) and expiration (09/14/2035)
- Indirect ownership positions disclosed for trusts and retirement plan trustee, improving transparency
Negative
- Disposition of 28,036.3817 common shares reported on 09/15/2025 without explanatory text in the filing
- Filing provides no narrative explaining the reason for the share disposal or the context of the option award
Insights
TL;DR: Officer disclosed a large share disposition and an option award; both are routine insider reporting items.
The Form 4 shows an officer-level insider reporting a disposition of 28,036.3817 common shares and the reported acquisition of a stock option for 26,231 underlying shares at a stated exercise price of $156.83. Dates and ownership by named trusts and a retirement plan trustee are explicitly provided, which supports traceability of indirect holdings. The filing appears complete with signature and date. No additional context on the reason for the disposition or the nature of the option award beyond the dates and exercise price is provided in the document.
TL;DR: Reported option award details are specific; exercisability and expiration dates are disclosed.
The derivative table discloses a stock option with an exercise price of $156.83, acquisition date 09/15/2025, exercisable from 09/15/2028 and expiring 09/14/2035, and shows 26,231 underlying shares. The filing also records indirect beneficial ownership by a retirement plan trustee and two trusts with explicit share amounts. The document does not include aggregate company-level insider totals beyond the lines reported, nor any narrative explanation of the transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 26,231 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
FAQ
What transactions did Shailesh Jejurikar report on Form 4 for PG?
What are the terms of the option reported by PG insider Shailesh Jejurikar?
Who signed the Form 4 and when was it filed?
What is Shailesh Jejurikar's role at Procter & Gamble as shown on the form?
AI-generated analysis. How Rhea-AI works. Not financial advice.
